Omicron wave during December 2022 - January 2023: access to pharmaceuticals and healthcare resources and impacts on health outcomes in Shenzhen, China
ABSTRACTPurpose This study described pharmaceutical and medical resource accessibility of COVID-19 treatment in Shenzhen, China during the peak of COVID-19 infection from December 2022 to January 2023, and examined its influence on clinical outcomes.Methods We surveyed Shenzhen residents on COVID-19...
Saved in:
Main Authors: | Jiayue Chen (Author), Haisu Feng (Author), Jiatong Sun (Author), Yawen Jiang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Africans' response to the January 2023 Omicron variant wave in China: the impact of COVID-19 vaccination status
by: Erick Thokerunga, et al.
Published: (2024) -
SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023
by: Mengyan Zhang, et al.
Published: (2024) -
Mild and moderate COVID-19 during Alpha, Delta and Omicron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022: A population-based surveillance study.
by: Brecht Ingelbeen, et al.
Published: (2024) -
Editors' message - December 2023
by: Erin D. Michos, et al.
Published: (2023) -
Editors' message December 2022
by: Nathan D. Wong, et al.
Published: (2022)